Stromme syndrome, an exceptionally rare genetic disorder, remains a topic of ongoing research and exploration. While its prevalence remains uncertain, experts estimate that it impacts fewer than one in a million births. The identification of this condition dates back to 1993, but it was not officially named Stromme syndrome until 2007. Throughout the years, scientists have made significant progress in understanding this disorder, particularly in identifying the specific gene responsible for its occurrence. Stromme syndrome follows an autosomal recessive pattern, further contributing to its uniqueness.
Understanding the CENPF Gene
The role of the CENPF gene in Stromme syndrome is crucial. This genetic disorder arises due to mutations in both copies of the CENPF gene. The CENPF gene is responsible for encoding a particular protein that plays a vital role in various cellular processes such as cell division, migration, and differentiation. However, when mutations occur in both copies of this gene, it leads to a slowdown in fetal cell division and ultimately disrupts embryonic development, causing it to come to a halt or be delayed.
First Known Case
In 1993, Dr. Peter Stromme made a groundbreaking discovery when he diagnosed the very first case of Stromme syndrome. This rare genetic disorder was identified in two sisters who displayed a distinct set of symptoms. The sisters exhibited digestive issues, eye abnormalities, and a condition called severe microcephaly, which is characterized by having a smaller than average head size.
Throughout their lives, both sisters experienced mild cognitive impairment and vision problems. Additionally, they struggled with fat malabsorption and had difficulty gaining weight. Despite these challenges, they managed to live into adulthood and lead independent lives.